ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 81.57% | 74.25% | -26.43% | 6.23% | -46.57% |
| Total Depreciation and Amortization | -47.37% | 923.08% | -82.89% | 1.33% | 7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.74% | -85.00% | 13.66% | 43.04% | 365.78% |
| Change in Net Operating Assets | 102.57% | -269.20% | 276.26% | -9,227.78% | -99.81% |
| Cash from Operations | 116.93% | -114.31% | 1.31% | 64.71% | -51.02% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 393.16% | 88.06% |
| Cash from Investing | -- | -- | -- | 308.94% | 83.25% |
| Total Debt Issued | -- | -100.00% | 156.22% | 106.04% | -5,667.41% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.12% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 1,836.12% | -100.93% | -- |
| Cash from Financing | -116.74% | 28.44% | 673.68% | -94.72% | 5,342.09% |
| Foreign Exchange rate Adjustments | -99.65% | 187.92% | -56.83% | -207.36% | -51.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.66% | 244.98% | 85.70% | -206.73% | 136.08% |
